Cargando…

Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011

BACKGROUND: Cryptococcosis due to Cryptococcus gattii is endemic in various parts of the world, affecting mostly immunocompetent patients. A national surveillance study of cryptococcosis, including demographical, clinical and microbiological data, has been ongoing since 1997 in Colombia, to provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Lizarazo, Jairo, Escandón, Patricia, Agudelo, Clara Inés, Firacative, Carolina, Meyer, Wieland, Castañeda, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238989/
https://www.ncbi.nlm.nih.gov/pubmed/25411779
http://dx.doi.org/10.1371/journal.pntd.0003272
_version_ 1782345539245834240
author Lizarazo, Jairo
Escandón, Patricia
Agudelo, Clara Inés
Firacative, Carolina
Meyer, Wieland
Castañeda, Elizabeth
author_facet Lizarazo, Jairo
Escandón, Patricia
Agudelo, Clara Inés
Firacative, Carolina
Meyer, Wieland
Castañeda, Elizabeth
author_sort Lizarazo, Jairo
collection PubMed
description BACKGROUND: Cryptococcosis due to Cryptococcus gattii is endemic in various parts of the world, affecting mostly immunocompetent patients. A national surveillance study of cryptococcosis, including demographical, clinical and microbiological data, has been ongoing since 1997 in Colombia, to provide insights into the epidemiology of this mycosis. METHODOLOGY/PRINCIPAL FINDINGS: From 1,209 surveys analyzed between 1997–2011, 45 cases caused by C. gattii were reported (prevalence 3.7%; annual incidence 0.07 cases/million inhabitants/year). Norte de Santander had the highest incidence (0.81 cases/million/year), representing 33.3% of all cases. The male: female ratio was 3.3∶1. Mean age at diagnosis was 41±16 years. No specific risk factors were identified in 91.1% of patients. HIV infection was reported in 6.7% of patients, autoimmune disease and steroids use in 2.2%. Clinical features included headache (80.5%), nausea/vomiting (56.1%) and neurological derangements (48.8%). Chest radiographs were taken in 21 (46.7%) cases, with abnormal findings in 7 (33.3%). Cranial CT scans were obtained in 15 (33.3%) cases, with abnormalities detected in 10 (66.7%). Treatment was well documented in 30 cases, with most receiving amphotericin B. Direct sample examination was positive in 97.7% cases. Antigen detection was positive for all CSF specimens and for 75% of serum samples. C. gattii was recovered from CSF (93.3%) and respiratory specimens (6.6%). Serotype was determined in 42 isolates; 36 isolates were serotype B (85.7%), while 6 were C (14.3%). The breakdowns of molecular types were VGII (55.6%), VGIII (31.1%) and VGI (13.3%). Among 44 strains, 16 MLST sequence types (ST) were identified, 11 of them newly reported. CONCLUSIONS/SIGNIFICANCE: The results of this passive surveillance study demonstrate that cryptococcosis caused by C. gattii has a low prevalence in Colombia, with the exception of Norte de Santander. The predominance of molecular type VGII is of concern considering its association with high virulence and the potential to evolve into outbreaks.
format Online
Article
Text
id pubmed-4238989
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42389892014-11-26 Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011 Lizarazo, Jairo Escandón, Patricia Agudelo, Clara Inés Firacative, Carolina Meyer, Wieland Castañeda, Elizabeth PLoS Negl Trop Dis Research Article BACKGROUND: Cryptococcosis due to Cryptococcus gattii is endemic in various parts of the world, affecting mostly immunocompetent patients. A national surveillance study of cryptococcosis, including demographical, clinical and microbiological data, has been ongoing since 1997 in Colombia, to provide insights into the epidemiology of this mycosis. METHODOLOGY/PRINCIPAL FINDINGS: From 1,209 surveys analyzed between 1997–2011, 45 cases caused by C. gattii were reported (prevalence 3.7%; annual incidence 0.07 cases/million inhabitants/year). Norte de Santander had the highest incidence (0.81 cases/million/year), representing 33.3% of all cases. The male: female ratio was 3.3∶1. Mean age at diagnosis was 41±16 years. No specific risk factors were identified in 91.1% of patients. HIV infection was reported in 6.7% of patients, autoimmune disease and steroids use in 2.2%. Clinical features included headache (80.5%), nausea/vomiting (56.1%) and neurological derangements (48.8%). Chest radiographs were taken in 21 (46.7%) cases, with abnormal findings in 7 (33.3%). Cranial CT scans were obtained in 15 (33.3%) cases, with abnormalities detected in 10 (66.7%). Treatment was well documented in 30 cases, with most receiving amphotericin B. Direct sample examination was positive in 97.7% cases. Antigen detection was positive for all CSF specimens and for 75% of serum samples. C. gattii was recovered from CSF (93.3%) and respiratory specimens (6.6%). Serotype was determined in 42 isolates; 36 isolates were serotype B (85.7%), while 6 were C (14.3%). The breakdowns of molecular types were VGII (55.6%), VGIII (31.1%) and VGI (13.3%). Among 44 strains, 16 MLST sequence types (ST) were identified, 11 of them newly reported. CONCLUSIONS/SIGNIFICANCE: The results of this passive surveillance study demonstrate that cryptococcosis caused by C. gattii has a low prevalence in Colombia, with the exception of Norte de Santander. The predominance of molecular type VGII is of concern considering its association with high virulence and the potential to evolve into outbreaks. Public Library of Science 2014-11-20 /pmc/articles/PMC4238989/ /pubmed/25411779 http://dx.doi.org/10.1371/journal.pntd.0003272 Text en © 2014 Lizarazo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lizarazo, Jairo
Escandón, Patricia
Agudelo, Clara Inés
Firacative, Carolina
Meyer, Wieland
Castañeda, Elizabeth
Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title_full Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title_fullStr Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title_full_unstemmed Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title_short Retrospective Study of the Epidemiology and Clinical Manifestations of Cryptococcus gattii Infections in Colombia from 1997–2011
title_sort retrospective study of the epidemiology and clinical manifestations of cryptococcus gattii infections in colombia from 1997–2011
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238989/
https://www.ncbi.nlm.nih.gov/pubmed/25411779
http://dx.doi.org/10.1371/journal.pntd.0003272
work_keys_str_mv AT lizarazojairo retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011
AT escandonpatricia retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011
AT agudeloclaraines retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011
AT firacativecarolina retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011
AT meyerwieland retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011
AT castanedaelizabeth retrospectivestudyoftheepidemiologyandclinicalmanifestationsofcryptococcusgattiiinfectionsincolombiafrom19972011